Our Portfolio 

Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.

 

For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.

DiscoverX_Corporation___Logo.jpg

DiscoverX provides innovative cell-based assays and services for drug discovery and development. It was acquired by Eurofins Pharma Discovery Services (EPDS) in 2017.

388373LOGO.jpg

Wellpartner is a leading provider of 340B Drug Pricing Program services It was acquired by CVS Health in 2018. 

Revelation Partners_Logo-01.png

255 California Street

12th Floor

San Francisco, CA 94111

Tel: 415-905-7226

  • LinkedIn

© 2020 by Revelation Partners